Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy

被引:9
|
作者
Boffa, GM
Zanco, P
Della Valentina, P
Cardaioli, P
Thiene, G
Chioin, R
Dalla Volta, S
机构
[1] Univ Padua, Sch Med, Dept Cardiol, I-35128 Padua, Italy
[2] Nucl Med PET Ctr, Veneto, Italy
[3] Univ Padua, Sch Med, Dept Cardiovasc Pathol, Padua, Italy
关键词
dilated cardiomyopathy; ischemic cardiomyopathy; positron emission tomography;
D O I
10.1016/S0167-5273(00)00245-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the utility of positron emission tomography in differentiating patients with idiopathic dilated cardiomyopathy from those with ischemic cardiomyopathy. Twenty consecutive non-diabetic patients with dilatation (end-diastolic volume greater than or equal to 120 cc/m(2)) and reduced systolic function (ejection fi action less than or equal to 40%) of the left ventricle on cineangiography, underwent coronary angiography, F18 fluorodeoxyglucose (F18-FDG) (glucose load technique) and N13-ammonia (N13-NH3) positron emission tomography. A semiquantitative score based on the extension and the severity of the uptake defects was calculated. Endomyocardial biopsy was performed in patients with normal coronary arteries. Ten patients (group A) had normal coronary arteries and histologic features of the endomyocardium fitting with the diagnosis of idiopathic dilated cardiomyopathy. Cineangiography showed critical stenosis of at least one major coronary artery in the other 10 patients (group B). The two groups were similar in age, left ventricular end-diastolic volume and ejection fraction. Both N13-NH3, positron emission tomography and F18-FDG position emission tomography scores were lower in group A than in group B: 0.1+/-0.3 vs. 10.6+/-5.1 (P<0.0001) and 2.4+/-4.4 vs. 9.9+/-4.1 (P<0.0001) respectively, but only N13-NH3 positron emission tomography allowed a complete separation of the two groups (score range 0-1 group A vs. 4-12 group B). The F18-FDG score value showed some overlapping between the two groups (score range 0-12 in the group A vs. 2-17 in the group B). All three idiopathic dilated cardiomyopathy patients with a F18-FDG score value >2 had left bundle branch block on standard EGG. Positron emission tomography imaging with N13-NH3 and F18-FDG provided a complete differentiation between idiopathic dilated cardiomyopathy and ischemic cardiomyopathy patients. However patients with left bundle branch block on ECG could present defects in FDG uptake even if affected by idiopathic diluted cardiomyopathy. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [41] Can positron emission tomography be useful to manage systemic sclerosis cardiac involvement?
    Elise Redureau
    Olivier Lairez
    Anne Hitzel
    Grégory Pugnet
    Journal of Nuclear Cardiology, 2017, 24 : 1814 - 1815
  • [42] Can positron emission tomography be useful to manage systemic sclerosis cardiac involvement?
    Redureau, Elise
    Lairez, Olivier
    Hitzel, Anne
    Pugnet, Gregory
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (05) : 1814 - 1815
  • [43] Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy
    Sciagra, Roberto
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 60 (04) : 354 - 361
  • [44] Myocardial Structural, Perfusion, and Metabolic Correlates of Left Bundle Branch Block Mechanical Derangement in Patients With Dilated Cardiomyopathy A Tagged Cardiac Magnetic Resonance and Positron Emission Tomography Study
    Masci, Pier Giorgio
    Marinelli, Martina
    Piacenti, Marcello
    Lorenzoni, Valentina
    Positano, Vincenzo
    Lombardi, Massimo
    L'Abbate, Antonio
    Neglia, Danilo
    CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (04) : 482 - U181
  • [45] Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
    Huang, Guangyong
    Huang, Zhiqi
    Peng, Yunling
    Wang, Yuehai
    Liu, Weitao
    Xue, Yuzeng
    Yang, Wenbo
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 1169 - 1184
  • [46] Positron emission tomography - A tool for identifying the effects of alcohol dependence on the brain
    Wong, DF
    Maini, A
    Rousset, OG
    Brasic, JR
    ALCOHOL RESEARCH & HEALTH, 2003, 27 (02): : 161 - 173
  • [47] Cardiovascular Positron Emission Tomography: A Possible Tool for Assessment of New Pharmaceuticals
    M. Schwaiger
    I. Kosa
    Drug information journal : DIJ / Drug Information Association, 1997, 31 (3): : 1029 - 1034
  • [48] Combined Positron Emission Tomography and Magnetic Resonance as Translational Tool in Cardiology
    Schwaiger, Markus
    CIRCULATION-CARDIOVASCULAR IMAGING, 2016, 9 (03)
  • [49] Positron emission tomography; viable tool in patients pre-CABG?
    E. E. van der Wall
    H. M. Siebelink
    A. J. Scholte
    J. J. Bax
    The International Journal of Cardiovascular Imaging, 2010, 26 : 661 - 664
  • [50] Idiopathic pulmonary fibrosis on F-18FDG positron emission tomography
    Lyburn, ID
    Lowe, JE
    Wong, WL
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (01) : 27 - 27